Evaluation of the Efficacy of Therapeutic Infiltrations of the Pudendal Nerve, Performed Under Neurostimulation on Pain, 1 Month After an Infiltration of Local Anaesthetic, in the Treatment of Pudendal Neuralgia.

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorGroupe Hospitalier Diaconesses Croix Saint-Simon

About this trial

Pudendal neuralgia (PN) is a chronic nerve compression syndrome causing neuropathic pain. Treatment includes medication, infiltration and decompressive surgery. Medicinal treatment involves the use of drugs that have proved effective in other areas, such as shingles or diabetes. There is no consensus on the molecules to be used for pudendal nerve infiltration (PNTI), and less than half of patients experience short-term relief. The only risk factor for failure is the duration of pain. Our study proposes to compare the usual treatment with a placebo, as no type of infiltration has been compared with a placebo.

Eligibility criteria

Qualifiers

Patient 18 years of age or older,

Expressed consent to participate in the study

Affiliated or beneficiary of a social security plan

With pudendal neuralgia (Nantes criteria "modified" Nantes criteria).

Disqualifiers

Patient benefiting from a legal protection measure

Pregnant or breastfeeding woman

General and/or local infection (fistulous or cutaneous suppuration of the anal margin) in progress

Known neurological pathology that may explain the pain

Trial design

Treatments tested in this trial

  • Lidocaine Injectable Solution
  • Saline Solution for Block

Treatment groups

60 Participants
are divided into 2 treatment groups